Dipeptidyl Peptidase-4 Modulates Left Ventricular Dysfunction in Chronic Heart Failure via Angiogenesis-Dependent and -Independent Actions
Author(s) -
Toshimasa Shigeta,
Morihiko Aoyama,
Yoshiyuki Bando,
Akio Monji,
Toko Mitsui,
Miwa Takatsu,
Xiang-Wu Cheng,
Takahiro Okumura,
Akihiro Hirashiki,
Kohzo Nagata,
Toyoaki Murohara
Publication year - 2012
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.112.096479
Subject(s) - medicine , dipeptidyl peptidase 4 , heart failure , cardiology , endocrinology , diabetes mellitus , angiogenesis , type 2 diabetes
The inhibition of dipeptidyl peptidase-4 (DPP4) protects the heart from acute myocardial ischemia. However, the role of DPP4 in chronic heart failure independent of coronary artery disease remains unclear.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom